Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296660 · ClinicalTrials.gov registry record
Acute HIV Infection Observational Study
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,300
- Enrollment target
NCT00296660: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00296660 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00296660 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,300 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data and body fluid samples from people with acute or established HIV infection and from HIV uninfected people. Data from this study will be used to better understand properties of HIV, including HIV transmission and the differences between acute and established HIV infections.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,300 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-06 |
What the finished NCT00296660 record still lists
NCT00296660 is an observational study that tracks outcomes without assigning an intervention. Its 1,300 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00296660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00296660 about?
NCT00296660 is a clinical study titled "Acute HIV Infection Observational Study". The purpose of this study is to collect data and body fluid samples from people with acute or established HIV infection and from HIV uninfected people. Data from this study will be used to better understand properties of HIV, including HIV transmission and the differences between acute and establish...
What is the current status of trial NCT00296660?
This trial is currently completed. The enrollment target is 1,300 participants. The study started on 2006-06. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00296660?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia